.Nature Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for introduction of individuals with MASLD as well as dimension of liver outcomes in cardio-- kidney-- metabolic trials, when records propose mechanistically tenable benefits as well as scientific safety-- and also lays out considerations for test layout as well as regulatory approval.